A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies

BACKGROUND: Neutralizing antibodies (NAbs) prevent pathogens from infecting host cells. Detection of SARS-CoV-2 NAbs is critical to evaluate herd immunity and monitor vaccine efficacy against SARS-CoV-2, the virus that causes COVID-19. All currently available NAb tests are lab-based and time-intensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kongsuphol, Patthara, Jia, Huan, Cheng, Hoi Lok, Gu, Yue, Shunmuganathan, Bhuvaneshwari D/O, Chen, Ming Wei, Lim, Sing Mei, Ng, Say Yong, Tambyah, Paul Ananth, Nasir, Haziq, Gao, Xiaohong, Tay, Dousabel, Kim, Seunghyeon, Gupta, Rashi, Qian, Xinlei, Kozma, Mary M., Purushotorman, Kiren, McBee, Megan E., MacAry, Paul A., Sikes, Hadley D., Preiser, Peter R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053278/
https://www.ncbi.nlm.nih.gov/pubmed/35602218
http://dx.doi.org/10.1038/s43856-021-00045-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053278/
https://www.ncbi.nlm.nih.gov/pubmed/35602218
http://dx.doi.org/10.1038/s43856-021-00045-9

Ejemplares similares